^
    No biomarker
    Anal Carcinoma
    MIXE
    Sensitive
    :
    A2
    No biomarker
    Anal Carcinoma
    TPF
    Sensitive
    :
    A2
    No biomarker
    Anal Carcinoma
    pembrolizumab
    Sensitive
    :
    A2
    No biomarker
    Anal Carcinoma
    nivolumab
    Sensitive
    :
    A2
    No biomarker
    Anal Carcinoma
    FOLFOX
    Sensitive
    :
    A2
    No biomarker
    Anal Carcinoma
    carboplatin + paclitaxel
    Sensitive
    :
    A2
    No biomarker
    Anal Carcinoma
    FOLFCIS
    Sensitive
    :
    A2
    No biomarker
    Anal Carcinoma
    cisplatin + 5-fluorouracil
    Sensitive
    :
    A2
    No biomarker
    Anal Carcinoma
    mFOLFOX6
    Sensitive
    :
    A2
    No biomarker
    Anal Carcinoma
    capecitabine + mitomycin
    Sensitive
    :
    A2
    No biomarker
    Anal Carcinoma
    5-fluorouracil + mitomycin
    Sensitive
    :
    A2
    No biomarker
    Anal Carcinoma
    INCMGA0012
    Sensitive
    :
    B
    PD-L1 expression
    Anal Carcinoma
    pembrolizumab
    Sensitive
    :
    C1
    VERI is free for non-commercial use, no login needed.
    Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
    For commercial access, including additional premium features, please contact us.
    By using VERI, you are agreeing to our
    and
    Privacy Policy
    ACCEPT COOKIES